20585286

Source:http://linkedlifedata.com/resource/pubmed/id/20585286

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023434, umls-concept:C1832027, umls-concept:C2724188
pubmed:issue	1341
pubmed:dateCreated	2010-6-29
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985240R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD20, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/ofatumumab
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1523-2859
pubmed:issnType	Electronic
pubmed:day	28
pubmed:volume	52
pubmed:owner	NLM
pubmed:pagination	51-2
pubmed:meshHeading	pubmed-meshheading:20585286-Animals, pubmed-meshheading:20585286-Antibodies, Monoclonal, pubmed-meshheading:20585286-Antigens, CD20, pubmed-meshheading:20585286-Antineoplastic Agents, pubmed-meshheading:20585286-Humans, pubmed-meshheading:20585286-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:20585286-Opportunistic Infections
pubmed:year	2010
pubmed:articleTitle	Ofatumumab (Arzerra) for CLL.
pubmed:publicationType	Journal Article, Review